| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mink Therapeutics, Inc. (INKT) has 7 insiders with recent SEC Form 4 filings, including 3 buys and 5 sells. INKT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 50.0K | $552.0K | - | |
| Dir | 20.4K | $225.3K | - | |
| Dir | 19.1K | $211.2K | - | |
| Dir | 5.4K | $59.6K | - | |
| Dir | 5.4K | $59.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Ryan Barbara | Director | Sell | 1,500 | $14.70 | $22,051.76 | -1.7% | - | - | |
| May 5, 2023 | Armen Garo H49 | Director | Sell | 100,000 | $0.95 | $94,850.00 | -5.1% | +8.9% | -38.0% | |
| May 2, 2023 | Armen Garo H49 | Director | Buy | 100,000 | $0.95 | $94,850.00 | +5.3% | +110.1% | +7.0% | |
| Jul 19, 2022 | Wiinberg Ulf52 | Director | Buy | 20,000 | $1.38 | $27,646.30 | +3.6% | +38.2% | +33.3% |